In the article “18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung Lesions,” by Singnurkar et al. (J Nucl Med. 2010;51:1833–1840), Table 2 contained an error. The corrected table appears below. The authors regret the error.
In the article “Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I,” by Ziebell et al. (J Nucl Med. 2010;51:1885–1891), the third and fourth sentences of the abstract contain errors and should read as follows: “In this study, we compared the SPECT radioligands 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane (123I-FP-CIT) and 123I-N-(3-iodoprop-2E-enyl)-2-β-carbomethoxy-3β-(4-methylphenyl)nortropane (123I-PE2I), which has a 10-fold higher selectivity than 123I-FP-CIT for DAT versus SERT.” We regret the errors.
- © 2011 by Society of Nuclear Medicine